Recombinant Eubacterium eligens Porphobilinogen deaminase (hemC)

Shipped with Ice Packs
In Stock

Description

Enzyme Overview

Porphobilinogen deaminase (PBGD; EC 4.3.1.8), encoded by the hemC gene, catalyzes the polymerization of four porphobilinogen (PBG) molecules into hydroxymethylbilane, a key step in heme biosynthesis. In Eubacterium eligens, this enzyme shares structural and functional similarities with PBGDs from other bacteria, such as Escherichia coli and human homologs .

Recombinant Production

Recombinant E. eligens PBGD is typically expressed in E. coli overexpression systems. For example:

  • Vector: Plasmid-based systems (e.g., pET-28a+) with inducible promoters (e.g., T7/lacO) .

  • Purification: Affinity chromatography (His-tag), yielding ~10–20 mg/L culture .

  • Crystallization: Achieved via vapor diffusion in ammonium sulfate/polyethylene glycol buffers .

Expression Challenges:

  • Solubility issues observed in some homologs (e.g., Clostridium paraputrificum 12β-HSDH) .

  • Codon optimization required for high-yield expression in E. coli .

Substrate Binding Dynamics:

  • Intermediate complexes (A–E) detected via anion-exchange chromatography .

  • Rate-limiting step at the C intermediate (dipyrrole-enzyme) .

Applications and Therapeutic Potential

Recombinant PBGD has been explored for:

  1. Acute Intermittent Porphyria (AIP): Liver-targeted delivery via apolipoprotein A-I fusion enhances hepatic activity and reduces porphyrin accumulation .

  2. Microbiome Engineering: CRISPR-Cpf1 systems from E. eligens enable gene editing in gut commensals .

Clinical Data (Rodent Models):

ParameterRecombinant PBGD EffectStudy Reference
Hepatic Activity3-fold increase post-administration
Neurological ProtectionBlood-brain barrier penetration demonstrated

Comparative Genomics

The hemC gene in E. eligens (GenBank: WP_027099077.1) shares 68% identity with E. coli HemC and 45% with human PBGD. Key genomic features:

  • Operon Structure: Co-localized with hemB and hemD in gram-positive bacteria .

  • Phylogeny: Clustered with E. rectale and Roseburia spp. in the Clostridia class .

Research Gaps and Future Directions

  1. Structural Biology: X-ray crystallography of E. eligens PBGD needed to resolve active-site variations.

  2. In Vivo Function: Role in butyrate production or cross-feeding interactions (e.g., acetate utilization) .

  3. Therapeutic Optimization: Fusion proteins (e.g., ApoAI-PBGD) require human trials .

Product Specs

Form
Lyophilized powder. We will ship the format we have in stock. If you have special format requirements, please note them when ordering, and we will accommodate your request.
Lead Time
Delivery time varies depending on the purchase method and location. Consult your local distributor for specific delivery times. All proteins are shipped with standard blue ice packs. For dry ice shipping, please contact us in advance; additional charges apply.
Notes
Avoid repeated freezing and thawing. Store working aliquots at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening to collect contents at the bottom. Reconstitute the protein in sterile deionized water to a concentration of 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer components, storage temperature, and protein stability. Liquid form typically has a 6-month shelf life at -20°C/-80°C. Lyophilized form typically has a 12-month shelf life at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
The tag type will be determined during the manufacturing process. If you have a specific tag type requirement, please inform us, and we will prioritize developing it.
Synonyms
hemC; EUBELI_00748; Porphobilinogen deaminase; PBG; EC 2.5.1.61; Hydroxymethylbilane synthase; HMBS; Pre-uroporphyrinogen synthase
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-295
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Eubacterium eligens (strain ATCC 27750 / VPI C15-48)
Target Names
hemC
Target Protein Sequence
MHYRIGTRGS KLALVQSEYV KRRMEEAYPE DTFELVIIKT TGDKVTDKPL AAIGTKGFFV KEIEEALLSG SIDMAVHSMK DMPAECAAGL TFAKAWKRED CRDVLILKTA GSFSELPSGA VIGTGSLRRA CQLAMLRPDI QFTAIRGNVD TRINKLMDDS YGLDGIVLAA AGLNRLGRSS EITEYLDPEV VIPAPAQGVL AIETAEVNTE LLDKINALSD DNSDREAVAE RTFLRLTGGG CHAPVGAHCV TKDNGDLRMV VLFGNDDCSR ILRIEVTGTD SEAVGHEAAR MLGLE
Uniprot No.

Target Background

Function
Tetrapolymerizes the monopyrrole PBG into the hydroxymethylbilane pre-uroporphyrinogen through several distinct steps.
Database Links
Protein Families
HMBS family

Q&A

What is porphobilinogen deaminase and what is its function in metabolic pathways?

Porphobilinogen deaminase (EC 4.3.1.8), also known as hydroxymethylbilane synthase, is a critical enzyme in the tetrapyrrole biosynthesis pathway. It catalyzes the polymerization of four porphobilinogen molecules to form hydroxymethylbilane, a linear tetrapyrrole that serves as a precursor for heme, chlorophyll, and other essential biological compounds. The enzyme contains a dipyrromethane cofactor covalently bound to the active site that functions as an anchor for the growing polypyrrole chain during synthesis. During catalysis, porphobilinogen binds to this cofactor to form three intermediate complexes: ES, ES2, and ES3, reflecting the sequential addition of substrate molecules .

In bacterial systems like Escherichia coli, the molecular weight of porphobilinogen deaminase has been determined to be approximately 33-35 kDa through various methods including SDS/polyacrylamide-gel electrophoresis (35,000) and gel filtration (32,000), which aligns with the gene-derived molecular weight of 33,857 .

What is Eubacterium eligens and why is it significant for research?

Eubacterium eligens is a motile, obligate anaerobic, Gram-positive, rod-shaped mesophilic bacterium that inhabits the human gut microbiome. First isolated in 1974 by W.E.C Moore and Lillian V. Holdeman from human fecal samples, E. eligens belongs to the Bacillota (previously Firmicutes) phylum, which constitutes a significant portion of the human gut microflora .

E. eligens holds particular scientific interest due to several distinctive characteristics:

  • It contributes to anti-inflammatory secretions in the gut microbiota

  • Unlike most Firmicutes species, it possesses the uncommon ability to degrade pectin, a capability typically associated with Bacteroidetes

  • It exhibits optimal growth at human body temperature (37°C) and can grow well up to 45°C

  • It demonstrates poor growth in the absence of fermentable carbohydrates, which is reflected in its name "eligens" (meaning "choosy")

The organism's genomic analysis reveals 2,723 total genes, comprising 2,613 protein-coding genes, 66 RNA genes, and 44 pseudogenes, with a genome size of 2.83 Mb .

How does the hemC gene function in bacterial systems?

The hemC gene encodes porphobilinogen deaminase in various bacterial species. In research contexts, this gene has been extensively studied in organisms such as Clostridium josui and Escherichia coli . The gene is an essential component of the heme biosynthesis pathway, which supports numerous critical biological processes.

The hemC gene product participates in the third step of the tetrapyrrole biosynthesis pathway, converting four molecules of porphobilinogen to hydroxymethylbilane. This reaction represents a critical branch point in tetrapyrrole metabolism that ultimately leads to the production of heme, chlorophyll, and related compounds depending on the organism.

Research has demonstrated that the hemC gene can be successfully cloned and expressed in heterologous systems. For example, the Clostridium josui hemC gene has been expressed in recombinant E. coli strains to produce porphobilinogen deaminase for detailed characterization studies . Similar approaches have been employed with E. coli's native hemC gene, allowing for the production of substantial quantities of the enzyme for structural and functional analyses .

What advantages does studying recombinant versus native porphobilinogen deaminase offer?

Recombinant expression of porphobilinogen deaminase provides several significant advantages over working with native enzymes:

AdvantageExplanationEvidence from Literature
Higher protein yieldsRecombinant systems can produce enzyme quantities suitable for comprehensive biochemical characterizationE. coli hemC-containing plasmid allowed purification of milligram quantities of enzyme
Enhanced purityRecombinant approaches facilitate isolation of homogeneous enzyme preparationsSuccessful crystallization of recombinant E. coli porphobilinogen deaminase demonstrates high purity achievement
Genetic manipulationEnables introduction of mutations, purification tags, and other modificationsVarious hemC genes have been successfully cloned and expressed in E. coli
Standardized comparisonExpression of enzymes from different species in a common host allows direct comparison of intrinsic propertiesComparative studies between C. josui and E. coli deaminases reveal distinct kinetic parameters
Practical feasibilityMany native organisms (especially anaerobes like E. eligens) are difficult to culture in sufficient quantitiesE. eligens is an obligate anaerobe requiring specific growth conditions

These advantages have been demonstrated in multiple studies, including those examining porphobilinogen deaminase from Clostridium josui (with optimal temperature of 65°C and pH of 7.0) and E. coli (with Km of 19 ± 7 μM and isoelectric point of 4.5) .

What expression conditions optimize recombinant E. eligens hemC production?

While the literature doesn't specifically address optimized conditions for E. eligens hemC expression, evidence from related systems provides valuable guidance:

Successful recombinant expression of porphobilinogen deaminase has been achieved with both Clostridium josui and E. coli hemC genes . Based on E. eligens' characteristics as a mesophilic, obligate anaerobe with a low GC content of 36% , the following expression conditions warrant consideration:

ParameterRecommended ApproachRationale
Host strainE. coli BL21(DE3) or Rosetta for rare codon supplementationE. eligens' low GC content (36%) suggests potential codon usage differences from E. coli
Temperature16-30°C for expression phaseLower temperatures often improve folding of recombinant proteins from mesophilic organisms
Oxygen conditionsMicroaerobic or anaerobic inductionMay better mimic native conditions for this obligate anaerobe
Media supplementsAddition of porphobilinogen or pathway intermediatesCould enhance cofactor incorporation and enzyme stability
Induction protocolLow inducer concentration with extended expression timeGradual expression often improves folding and solubility

Given E. eligens' optimal growth temperature of 37°C with growth capability up to 45°C , its porphobilinogen deaminase likely exhibits different stability characteristics compared to the thermostable C. josui enzyme (which retains 86% activity after 1 hour at 70°C) .

How do biochemical properties of bacterial porphobilinogen deaminases compare?

Comparative analysis of bacterial porphobilinogen deaminases reveals distinctive biochemical properties that reflect evolutionary adaptations to different ecological niches:

PropertyC. josui DeaminaseE. coli DeaminasePredicted E. eligens Deaminase
Optimal temperature65°C Not specifiedLikely ~37°C (based on optimal growth temperature)
Optimal pH7.0 Not specifiedLikely near neutral (gut environment)
ThermostabilityRetains 86% activity after 1h at 70°C Not specifiedLikely moderate (mesophilic organism)
Km value65 μM 19 ± 7 μM Unknown
Vmax3.3 μmol/h/mg Not specifiedUnknown
Molecular weightNot specified~33-35 kDa Likely similar to other bacterial deaminases
Isoelectric pointNot specified4.5 Unknown

The substantial difference in Km values between C. josui and E. coli enzymes suggests species-specific adaptations in substrate binding affinity. The thermostability of the C. josui enzyme is particularly notable, reflecting its adaptation to higher temperature environments compared to human gut-associated bacteria like E. eligens .

What purification strategies are most effective for recombinant hemC-encoded enzymes?

Effective purification of recombinant porphobilinogen deaminase requires a strategic approach that accounts for the enzyme's specific biochemical properties:

Step-wise purification strategy:

  • Initial capture:

    • Affinity chromatography using engineered tags (His₆, GST) if incorporated into the recombinant construct

    • Ammonium sulfate fractionation as an alternative first step

  • Intermediate purification:

    • Ion exchange chromatography: Anion exchange at neutral pH is effective given the acidic isoelectric point (4.5) of E. coli porphobilinogen deaminase

    • Selective thermal treatment for thermostable variants (demonstrated effective for C. josui enzyme that retains 86% activity after 1h at 70°C)

  • Polishing:

    • Size exclusion chromatography for final purification and determination of oligomeric state

    • Crystallization trials for structural studies, as demonstrated with E. coli porphobilinogen deaminase

For E. eligens porphobilinogen deaminase specifically, considerations should include its likely moderate thermostability (as a mesophilic organism) and potential optimization of purification buffers to maintain enzyme stability during the isolation process.

What kinetic mechanisms govern porphobilinogen deaminase activity?

Porphobilinogen deaminase exhibits complex kinetic behavior reflecting its multi-step catalytic mechanism:

The enzyme catalyzes the sequential addition of four porphobilinogen molecules to form tetrapyrrole hydroxymethylbilane. This process involves the formation of distinct enzyme-substrate intermediates (ES, ES2, and ES3) as documented for the E. coli enzyme . The dipyrromethane cofactor serves as the initial acceptor for the first substrate molecule, followed by sequential addition of subsequent porphobilinogen units.

Kinetic parameters vary significantly between bacterial species:

Kinetic ParameterC. josui DeaminaseE. coli Deaminase
Km65 μM 19 ± 7 μM
Vmax3.3 μmol/h/mg Not specified
SubstratePorphobilinogenPorphobilinogen
IntermediatesNot specifiedES, ES2, ES3

The lower Km value for the E. coli enzyme indicates higher substrate affinity compared to the C. josui enzyme. These differences likely reflect adaptations to different cellular environments and metabolic requirements. For E. eligens porphobilinogen deaminase, kinetic properties would likely reflect adaptations to the human gut environment, potentially with parameters optimized for the specific conditions encountered in this ecological niche .

How does protein structure influence porphobilinogen deaminase function?

The three-dimensional structure of porphobilinogen deaminase plays a crucial role in determining its catalytic properties, substrate specificity, and stability:

E. coli porphobilinogen deaminase has been successfully crystallized , providing insights into its structural organization. The enzyme contains a covalently bound dipyrromethane cofactor at the active site that serves as the anchor point for the growing polypyrrole chain during catalysis. This cofactor is essential for the formation of the three reaction intermediates (ES, ES2, and ES3) .

For E. eligens porphobilinogen deaminase, structural features would likely reflect adaptations to its mesophilic, anaerobic gut environment . Key structural considerations include:

  • Active site architecture: The configuration of residues involved in substrate binding contributes to the observed differences in Km values between bacterial species (65 μM for C. josui vs. 19 μM for E. coli)

  • Thermostability determinants: Structural elements that contribute to the remarkable thermostability of the C. josui enzyme (retaining 86% activity after 1h at 70°C) versus the likely moderate stability of E. eligens enzyme

  • Cofactor interactions: The manner in which the dipyrromethane cofactor is anchored and protected within the protein structure

  • Domain organization: The arrangement of structural domains that facilitate the sequential addition of substrate molecules during the multi-step catalytic process

Computational approaches such as homology modeling based on the E. coli enzyme structure could provide initial insights into these structural features for the E. eligens enzyme.

What challenges arise in heterologous expression of E. eligens proteins?

Expressing proteins from anaerobic gut bacteria like E. eligens in heterologous systems presents several challenges that require specialized experimental approaches:

ChallengeExperimental ApproachRationale
Codon usage biasCodon optimization for expression hostE. eligens has low GC content (36%) compared to typical expression hosts
Protein misfoldingExpression at reduced temperatures (16-25°C)Slower expression can improve folding of challenging proteins
Cofactor incorporationSupplementation with pathway intermediatesEnsures proper incorporation of the dipyrromethane cofactor
Oxygen sensitivityAnaerobic or microaerobic expression conditionsE. eligens is an obligate anaerobe
Protein solubilityFusion with solubility-enhancing tags (MBP, SUMO)Improves solubility and prevents aggregation
Proteolytic degradationCo-expression with chaperones (GroEL/ES, DnaK/J)Stabilizes folding intermediates and prevents degradation

E. eligens' optimal growth at 37°C with growth capability up to 45°C contrasts with the thermophilic nature of C. josui (enzyme retains 86% activity after 1h at 70°C) , suggesting different approaches may be needed for optimal expression and stabilization of these enzymes in recombinant systems.

How can site-directed mutagenesis enhance recombinant porphobilinogen deaminase properties?

Site-directed mutagenesis represents a powerful approach for understanding and engineering porphobilinogen deaminase properties:

Potential mutagenesis targets and strategies:

Comparative analysis of C. josui and E. coli deaminases could identify key residues responsible for their different kinetic properties , providing rational targets for engineering improved variants of the E. eligens enzyme.

What emerging applications exist for recombinant porphobilinogen deaminase in research?

Recombinant porphobilinogen deaminase from gut bacteria like E. eligens has several cutting-edge research applications:

  • Microbiome metabolism studies:

    • Investigating tetrapyrrole metabolism in the human gut microbiome

    • Understanding E. eligens' metabolic roles in the gut ecosystem

    • Exploring connections between tetrapyrrole metabolism and anti-inflammatory effects observed with E. eligens

  • Structural biology advancements:

    • Comparative analysis of deaminases from diverse bacterial species

    • Time-resolved crystallography to capture reaction intermediates (ES, ES2, ES3)

    • Cryogenic electron microscopy of enzyme-substrate complexes

  • Metabolic engineering:

    • Enhancing tetrapyrrole production in recombinant systems

    • Engineering synthetic microbial consortia with optimized heme metabolism

    • Developing E. eligens as a platform for beneficial gut metabolite production

  • Biocatalysis applications:

    • Utilizing the thermostability of bacterial deaminases (like C. josui enzyme) for industrial processes

    • Engineering enzyme variants with enhanced activity or altered substrate specificity

    • Developing immobilized enzyme systems for continuous tetrapyrrole synthesis

  • Therapeutic research:

    • Exploring connections between gut microbiome heme metabolism and host health

    • Understanding porphyria-related disorders

    • Investigating E. eligens' anti-inflammatory properties in relation to tetrapyrrole metabolism

The distinct properties of each bacterial porphobilinogen deaminase—thermostability in C. josui , well-characterized intermediates in E. coli , and adaptation to the gut environment in E. eligens —provide complementary advantages for these diverse applications.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.